Who is sponsoring NCT03901703?

NCT03901703 is sponsored by Melek Volkan Yazici.

What drugs are being tested in NCT03901703?

Interventions in NCT03901703: Physiotherapy and Rehabilitation.

What condition does NCT03901703 study?

NCT03901703 studies Spastic Cerebral Palsy.

Is NCT03901703 still recruiting?

NCT03901703 is currently completed. Last updated 30 July 2019.

Last reviewed 2019-07-30 · How we verify

NCT03901703

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Functional Strengthening in Spastic Cerebral Palsy

Completed NA Last updated 30 July 2019

What this trial tests

NA trial testing Physiotherapy and Rehabilitation in Spastic Cerebral Palsy in 27 participants. Completed in 30 May 2019.

Timeline

12 January 2019

Primary endpoint
15 May 2019

30 May 2019

Quick facts

Lead sponsor	Melek Volkan Yazici
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	27
Start date	12 January 2019
Primary completion	15 May 2019
Estimated completion	30 May 2019
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Physiotherapy and Rehabilitation

Conditions studied

Spastic Cerebral Palsy — all drugs for Spastic Cerebral Palsy →

Sponsor

Melek Volkan Yazici

Who can join

Adults 5 to 15, any sex, with Spastic Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Functional strengthening exercises have been proven to be effective in patients with spastic cerebral palsy. However, which exercise is the most effective is unknown. The aim of this study is to examine the effectiveness of three different progressive functional exercise programs in children with unilateral and bilateral spastic cerebral palsy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of progressive functional ankle exercises in spastic cerebral palsy, plantarflexors versus dorsiflexors: a randomized trial.
Volkan Yazici M, Çobanoğlu G, Yazici G, Elbasan B. · · 2023 · cited 2× · PMID 38812998 · DOI 10.55730/1300-0144.5682

Verify or expand the search:

Other trials of Physiotherapy and Rehabilitation

Trials testing the same drug.

NCT06009380 — Effectiveness of Dual Task Training in Total Knee Arthroplasty · NA · completed
NCT05029544 — Dynamic Taping in Symptomatic Rotator Cuff Tendinopathy · NA · completed

Other recruiting trials for Spastic Cerebral Palsy

Currently open trials in the same condition.

NCT06925425 — Effect of Task Specific Electrical Stimulation on Upper Limb Gross Motor Skills in Children With Spastic Quadriplegia · NA · recruiting
NCT06902168 — Effect of Diving and Aquatic Exercises on Muscle Spasticity and Motor Function in Children With Spastic Cerebral Palsy · NA · recruiting
NCT06070233 — Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy · NA · recruiting
NCT06532981 — The Effect of AFOs on the EMG of Children With CP · recruiting
NCT05571033 — Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy · NA · recruiting

Other Melek Volkan Yazici trials

Trials by the same sponsor.

NCT06761664 — Decreasing Edema with Platysma Exercises Following Third Molar Extraction Surgery · NA · completed
NCT07266064 — Repeated Botulinum Toxin Type A Injections on Intramuscular Fat Accumulation in Individuals With Sleep Bruxism. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03901703 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Melek Volkan Yazici
Last refreshed: 30 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03901703.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing